Saskatchewan Tenders #ACAN-800011526A-2

Procurement of Sentimag SMB03 Platform for Breast Lesion Localization and Sentinel Lymph Node Biopsy

This procurement opportunity from the Saskatchewan Health Authority seeks a specialized medical platform for breast lesion localization and sentinel lymph node biopsy. - Government Buyer: - Saskatchewan Health Authority (SHA), Procurement Office - OEM/Vendor: - Hologic Canada ULC (OEM and named vendor) - Products/Services Requested: - Sentimag SMB03 platform (single console and probe system) - Part number: Sentimag SMB03 - Quantity: 1 - Includes: - Non-radioactive lymphatic tracer (injectable up to 30 days before surgery) - Stainless steel seed (placeable any time prior to surgery) - Unique/Notable Requirements: - System must support both breast lesion localization and sentinel lymph node biopsy - Audible and visual indication of probe proximity - 360-degree detection capability - Immunity to interference from tissue type, hematomas, and surgical lighting - Other Details: - Advance Contract Award Notice (ACAN) allows other suppliers to submit statements of capabilities if they can meet all requirements - No alternative OEMs or part numbers specified

Description

The Saskatchewan Health Authority (SHA) intends to award a contract for the provision of the Sentimag SMB03 platform to Hologic Canada ULC. This Advance Contract Award Notice (ACAN) allows other suppliers to submit statements of capabilities within a ten business day period to demonstrate their ability to meet the requirements. The platform must include a single console and probe system for breast lesion localization and sentinel lymph node biopsy, a non-radioactive lymphatic tracer injectable up to 30 days prior to surgery, and a stainless steel seed placeable at any time prior to surgery. Minimum essential requirements include audible and visual probe proximity indication, 360-degree detection, and immunity to interference from tissue type, hematomas, and surgical lighting.

View original listing